請用此 Handle URI 來引用此文件:
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/5962
完整後設資料紀錄
DC 欄位 | 值 | 語言 |
---|---|---|
dc.contributor.advisor | 魏志平(Chih-Ping Wei) | |
dc.contributor.author | Kuei-an Chen | en |
dc.contributor.author | 陳奎安 | zh_TW |
dc.date.accessioned | 2021-05-16T16:18:49Z | - |
dc.date.available | 2013-12-31 | |
dc.date.available | 2021-05-16T16:18:49Z | - |
dc.date.copyright | 2013-08-20 | |
dc.date.issued | 2013 | |
dc.date.submitted | 2013-08-14 | |
dc.identifier.citation | Adams, C. P., & Brantner, V. V. (2006). Estimating the cost of new drug development: Is it really $802 million? Health Affairs, 25(2), pp. 420-428.
Ashburn, T. T., & Thor, K. B. (2004). Drug repositioning: identifying and developing new uses for existing drugs. Nature Reviews Drug Discovery, 3(8), pp. 673-683. Campillos, M., Kuhn, M., Gavin, A.-C., Jensen, L. J., & Bork, P. (2008). Drug target identification using side-effect similarity. Science, 321(5886), pp. 263-266. Celgene Corporation. (2006). 2005 Annual Report. Summit, NJ: Celgene Corporation. Celgene Corporation. (2009). 2008 Annual Report on Form 10-K. Summit, NJ: Celgene Corporation. Celgene Corporation. (2013). 2012 Annual Report on Form 10-K. Summit, NJ: Celgene Corporation. Cheng, F., Liu, C., Jiang, J., Lu, W., Li, W., Liu, G., . . . Tang, Y. (2012). Prediction of drug-target interactions and drug repositioning via network-based inference. PLoS Computational Biology, 8(5), p. e1002503. Cilibrasi, R. L., & Vitányi, P. M. (2007). The Google similarity distance. IEEE Transactions on Knowledge and Data Engineering, 19(3), pp. 370-383. Davis, A., King, B. L., Mockus, S., Murphy, C. G., Saraceni-Richards, C., Rosenstein, M., . . . Mattingly, C. J. (2013). The Comparative Toxicogenomics Database: update 2013. Nucleic Acids Research, 39(suppl 1), pp. D1067-D1072. DiMasi, J. A., & Grabowski, H. G. (2007). The cost of biopharmaceutical R&D: Is biotech different? Managerial and Decision Economics, 28(4-5), pp. 469-479. Frijters, R., van Vugt, M., Smeets, R., van Schaik, R., de Vlieg, J., & Alkema, W. (2010). Literature mining for the discovery of hidden connections between drugs, genes and diseases. PLoS Computational Biology, 6(9), p. e1000943. Hamosh, A., Scott, A. F., Amberger, J. S., Bocchini, C. A., & McKusick, V. A. (2005). Online Mendelian Inheritance in Man (OMIM), a knowledgebase of human genes and genetic disorders. Nucleic Acids Research, 33(suppl 1), pp. D514-D517. Hristovski, D., Peterlin, B., Mitchell, J. A., & Humphrey, S. M. (2005). Using literature-based discovery to identify disease candidate genes. International Journal of Medical Informatics, 74, pp. 289-298. Katz, L. (1953). A new status index derived from sociometric analysis. Psychometrika, 18(1), pp. 39-43. Knox, C., Law, V., Jewison, T., Liu, P., Ly, S., Frolkis, A., . . . Wishart, D. S. (2011). DrugBank 3.0: A comprehensive resource for 'omics' research on drugs. Nucleic Acids Research, 39(suppl 1), pp. D1035-D1041. Lee, H., Bae, T., Lee, J.-H., Kim, D., Oh, Y., Jang, Y., . . . Kim, S. (2012). Rational drug repositioning guided by an integrated pharmacological network of protein, disease and drug. BMC Systems Biology, 6(1), p. 80. Lee, S., Choi, J., Park, K., Song, M., & Lee, D. (2012). Discovering context-specific relationships from biological literature by using multi-level context terms. BMC Medical Informatics and Decision Making, 12(Suppl 1), p. S1. Li, J., & Lu, Z. (2012). A new method for computational drug repositioning. 2012 IEEE International Conference on Bioinformatics and Biomedicine, (pp. 1-4). Philadelphia, PA. Li, J., Zhu, X., & Chen, J. Y. (2009). Building disease-specific drug-protein connectivity maps from molecular interaction networks and PubMed abstracts. PLoS Computational Biology, 5(7), p. e1000450. Liben-Nowell, D., & Kleinberg, J. (2007). The link prediction problem for social networks. Journal of the American Society for Information Science and Technology, 58(7), pp. 1019-1037. Lindsey, R., Veksler, V. D., Grintsvayg, A., & Gray, W. D. (2007). Be wary of what your computer reads: The effects of corpus selection on measuring semantic relatedness. Proceedings of ICCM 2007: Eighth International Conference on Cognitive Modeling (pp. 279-284). Oxford, UK: Taylor & Francis/Psychology Press. Lu, Z., & Wilbur, W. (2009). Improving accuracy for identifying related PubMed queries by an integrated approach. Journal of Biomedical Informatics, 42(5), pp. 831-838. McBride, W. G. (1961). Thalidomide and congenital abnormalities. Lancet, 278(7216), p. 1358. National Institutes of Health. (2009, 5 20). NIH Announces New Program to Develop Therapeutics for Rare and Neglected Diseases. (National Institutes of Health) Retrieved 12 2, 2012, from NIH News: http://www.nih.gov/news/health/may2009/nhgri-20.htm Özgür, A., Vu, T., Erkan, G., & Radev, D. R. (2008). Identifying gene-disease associations using centrality on a literature mined gene-interaction network. Bioinformatics, 24(13), pp. i277-i285. Pharmaceutical Research and Manufacturers of America. (2007). Drug Discovery and Development: Understanding the R&D Process. Washington, DC: Pharmaceutical Research and Manufacturers of America. Qu, X. A., Gudivada, R. C., Jegga, A. G., Neumann, E. K., & Aronow, B. J. (2009). Inferring novel disease indications for known drugs by semantically linking drug action and disease mechanism relationships. BMC Bioinformatics, 10(Suppl 5), p. S4. Srinivasan, P. (2004). Text mining: Generating hypotheses from MEDLINE. Journal of the American Society for Information Science and Technology, 55(5), pp. 396-413. Stephens, T. D., & Brynner, R. (2001). Dark Remedy: The Impact of Thalidomide and Its Revival as a Vital Medicine. Cambridge, MA: Perseus Publishing. Swanson, D. R. (1986). Fish oil, Raynaud's syndrome, and undiscovered public knowledge. Perspectives in Biology and Medicine, 30(1), pp. 7-18. Swanson, D. R. (1988). Migraine and magnesium: eleven neglected connections. Perspectives in biology and medicine, 31(4), pp. 526-557. Swanson, D. R., & Smalheiser, N. R. (1997). An interactive system for finding complementary literatures: A stimulus to scientific discovery. Artificial Intelligence, 91(2), pp. 183-203. Thomson Reuters. (2012, 9). White Paper: Knowledge-based Drug Repositioning to Drive R&D Productivity. Philadelphia, PA: Thomson Reuters. Retrieved 6 14, 2013, from http://ip-science.thomsonreuters.com/info/drugrepositioning/ Weeber, M., Klein, H., de Jong-van den Berg, L. T., & Vos, R. (2001). Using concepts in literature-based discovery: Simulating Swanson's Raynaud–fish oil and migraine–magnesium discoveries. Journal of the American Society for Information Science and Technology, 52(7), pp. 548-557. Wren, J. D., Bekeredjian, R., Stewart, J. A., Shohet, R. V., & Garner, H. R. (2004). Knowledge discovery by automated identification and ranking for implicit relationships. Bioinformatics, 20(3), pp. 389-398. Yang, L., & Agarwal, P. (2011). Systematic drug repositioning based on clinical side-effects. PLoS ONE, 6(12), p. e28025. Yetisgen-Yildiz, M., & Pratt, W. (2006). Using statistical and knowledge-based approaches for literature-based discovery. Journal of Biomedical Informatics, 39(6), pp. 600-611. Yetisgen-Yildiz, M., & Pratt, W. (2009). A new evaluation methodology for literature-based discovery systems. Journal of Biomedical Informatics, 42(4), pp. 633-643. | |
dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/5962 | - |
dc.description.abstract | 新藥物的推出能為藥品公司帶來相當的收入。然而,典型的新藥開發需要耗費大量資金與時間,且通過實驗、順利上市的成功率相當低,因此大部分的投資無法回收。近年來,許多藥品公司逐漸引入「舊藥新用」作為藥品開發的替代研發方法。「舊藥新用」是從既有的藥物,在其原本設計標的之外,尋找新適應症的藥物開發方式;由於既有藥物已經有許多前置研究基礎,可以省去許多臨床前評估與測試,藥品公司因而可以減少開發的時間與資金成本。
本研究基於Swanson提出的文獻探勘方法,分析超過15,000,000篇生物醫學文獻、以及藥物與疾病之知識庫,以自動化尋找尚未被發現且可能有直接關聯的既有藥物與疾病關係。我們建立三個實驗情境以評估本研究所提出之方法效能,其結果顯示,本研究提出之方法與所建構之綜合生物醫學概念網路能有效較既有方法有效提供潛在的藥物與疾病關係給研究者,以幫助研究者尋找可能的舊藥之新用途。 | zh_TW |
dc.description.abstract | Drug development is time-consuming and costly. However, most of drug development projects fail before they ever enter into clinical trials. To reduce the high risk of failure for drug development, pharmaceutical companies are exploring the drug repositioning approach for drug development. Previous studies have shown the feasibility of using computational methods to help extract plausible drug repositioning candidates, but they all encountered some limitations. We thus propose a novel drug-repositioning discovery method that takes into account multiple information sources, including more than 15,000,000 biomedical research articles and existing ontologies that cover detailed information about drugs, proteins and diseases, and follow the ABC model derived from Swanson’s literature-based discovery works. We design three experiments to evaluate our proposed drug repositioning discovery method. The results show that our proposed method and our proposed integrated information source can better help researchers sift plausible drug-disease relationships in comparison with existing techniques. | en |
dc.description.provenance | Made available in DSpace on 2021-05-16T16:18:49Z (GMT). No. of bitstreams: 1 ntu-102-R00725020-1.pdf: 966524 bytes, checksum: 02e6aff0b4af9828aeddcf0cc61c7510 (MD5) Previous issue date: 2013 | en |
dc.description.tableofcontents | 口試委員會審定書 i
誌謝 ii 中文摘要 iii ABSTRACT iv CONTENTS v LIST OF FIGURES vii LIST OF TABLES viii Chapter 1 Introduction 1 1.1 Background 1 1.2 Research Motivation and Objective 4 Chapter 2 Literature Review 7 2.1 Literature-based Approach 7 2.2 Ontology-based Approach 10 Chapter 3 Design of Drug Repositioning Discovery Method 13 3.1 Literature-based Concept Network Construction 14 3.1.1. Data Collection 15 3.1.2. Link Extraction and Filtering 16 3.2 Ontology-based Concept Network Construction 17 3.2.1. Data Collection 17 3.2.2. Concept Mapping 19 3.2.3. Link Extraction and Filtering 19 3.3 Related Concept Retrieval 20 3.4 Link Weighting 22 3.5 Target Term Ranking 23 3.5.1 Single Intermediate Level Scenario 24 3.5.2 Multiple Intermediate Levels Scenario 25 Chapter 4 Evaluation and Results 26 4.1 Evaluation Design 26 4.2 Experiment 1: Comprehensive Network and Link Weighting Algorithm 27 4.3 Experiment 2: Target Term Ranking Algorithms for Single Intermediate Level Scenario 29 4.4 Experiment 3: Multiple Intermediate Levels Scenario 31 4.4.1 Parameter Tuning 31 4.4.2 Experiment Result 34 Chapter 5 Conclusion and Future Work 36 References 38 | |
dc.language.iso | en | |
dc.title | 建構生物醫學文獻與知識庫探勘技術以尋找舊藥之新用途 | zh_TW |
dc.title | Mining Biomedical Literature and Ontologies for Drug Repositioning Discovery | en |
dc.type | Thesis | |
dc.date.schoolyear | 101-2 | |
dc.description.degree | 碩士 | |
dc.contributor.oralexamcommittee | 吳怡瑾(I-Chin Wu),曾新穆(Shin-Mu Tseng) | |
dc.subject.keyword | 舊藥新用,文獻探勘,醫學文獻探勘, | zh_TW |
dc.subject.keyword | Drug repositioning,Drug repurposing,Literature-based discovery,Medical literature mining, | en |
dc.relation.page | 41 | |
dc.rights.note | 同意授權(全球公開) | |
dc.date.accepted | 2013-08-14 | |
dc.contributor.author-college | 管理學院 | zh_TW |
dc.contributor.author-dept | 資訊管理學研究所 | zh_TW |
顯示於系所單位: | 資訊管理學系 |
文件中的檔案:
檔案 | 大小 | 格式 | |
---|---|---|---|
ntu-102-1.pdf | 943.87 kB | Adobe PDF | 檢視/開啟 |
系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。